RAYMOND JAMES & ASSOCIATES - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 58 filers reported holding HOMOLOGY MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$18,625
+32.2%
15,9190.0%0.00%
Q2 2023$14,088
-14.1%
15,9190.0%0.00%
Q1 2023$16,397
-18.3%
15,9190.0%0.00%
Q4 2022$20,058
-25.7%
15,919
-5.6%
0.00%
Q3 2022$27,000
-18.2%
16,8690.0%0.00%
Q2 2022$33,000
-35.3%
16,8690.0%0.00%
Q1 2022$51,00016,8690.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$16,511,0003.10%
Vida Ventures Advisors, LLC 770,845$2,806,0001.05%
Vivo Capital, LLC 853,143$3,105,0000.19%
AAF Wealth Management, LLC 47,501$173,0000.12%
OUP Management Co., LLC 64,000$233,0000.10%
GSA CAPITAL PARTNERS LLP 195,596$712,0000.09%
Temasek Holdings (Private) Ltd 5,650,996$20,570,0000.07%
Bellevue Group AG 1,737,122$6,323,0000.06%
XTX Topco Ltd 26,212$95,0000.05%
Virtus ETF Advisers LLC 37,588$137,0000.05%
View complete list of HOMOLOGY MEDICINES INC shareholders